Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Schwann cell differentiation pathway describes the sequence of molecular and cellular events by which neural crest cells develop into mature Schwann cells, which are essential glial cells in the peripheral nervous system. This process involves several intermediate stages, tightly regulated by extracellular signals, transcription factors, and intracellular signaling pathways. Key regulators include Neuregulin-1, Notch signaling, GPR126, cAMP, and transcription factors like Sox10, Oct-6, and Krox20. Disruptions in this pathway can lead to various neuropathies and nerve-related disorders.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Schwann Cell Differentiation Pathway (N/A).